ABN Newswire -- Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharmaceutical” or the “Group”, HKG:8221), an integrated research-driven and market-oriented pharmaceutical group in China, today announced its interim results for the six months ended 30 June 2009 (the “period under review”).
